About LA CaTS


PCORI, LA CaTS Weight Loss Trial in Underserved Population Highlighted Nationally

Released: Friday, October 02, 2020
Dr Katzmarzyk

LA CaTS Center’s own Dr. Peter Katzmarzyk, Pennington Biomedical Research Center, is nationally highlighted for his weight loss trial in low income, underserved Americans. Dr. Katzmarzyk’s study “Promoting Successful Weight Loss in Primary Care in Louisiana (PROPEL)” was published in the prestigious New England Journal of Medicine in early September. Other LA CaTS Center contributors on the trial include health literacy experts Drs. Terry Davis and Connie Arnold from LSU Health Sciences Center-Shreveport, Pennington Biomedical biostatistician Dr. William Johnson, community engagement researchers Drs. Daniel Sarpong and Kathleen Kennedy from Xavier University, Dr. Vivian Fonseca from Tulane University, and Dr. Eboni Price-Haywood from Ochsner Healthcare. PROPEL is a trial supported by the Patient-Center Outcomes Research Institute (PCORI), the LA CaTS Center IDeA-CTR and the NIDDK sponsored Pennington/Louisiana NORC. Click on the links below to view some of the media highlights. Congratulations to Dr. Katzmarzyk, the co-investigators and study team on their success and for tackling this important health issue affecting the underserved population in our state. 

Weight-loss coaches can make a big difference, Pennington finds. Should insurance cover them?­ – The Advocate interviews Dr. Peter Katzmarzyk, Associate Executive Director for Population and Public Health Sciences, about the PROPEL study.


Pennington Biomedical releases new study on weight-loss in underserved Louisiana communities – WAFB has a story on PROPEL, with comments from Dr. Peter Katzmarzyk, Associate Executive Director for Population and Public Health Sciences. The story is broadcast at 4 p.m., 5 p.m. and


Pennington finds success with targeted low-income weight loss program – WWL Radio posts the Louisiana Radio Network interview with Dr. Peter Katzmarzyk, Associate Executive Director for Population and Public Health Sciences, about the PROPEL study.


Other website highlights:

High-Intensity Lifestyle Treatment Beneficial for Obesity in Underserved - https://bit.ly/352vmiv – Drugs.com

Primary Care Program on Obesity Helped Disadvantaged Patients. Maybe no surprise, but serving the underserved panned out in trialhttps://www.medpagetoday.com/primarycare/obesity/88429 

PROPEL trial: Primary care intervention helps low-income populations lose weight - https://bit.ly/2GrIvYn - Healio

New Weight-Loss Program Shows Promise Among Low-Income Americans - https://bit.ly/32SfxZg - HealthDay

New Weight-Loss Program Shows Promise Among Low-Income Americans



About the Louisiana Clinical and Translational Science (LA CaTS) Center
The LA CaTS Center is comprised of three primary collaborating institutions in the state, including LSU's Pennington Biomedical Research Center in Baton Rouge, LSU Health Sciences Center in New Orleans, and Tulane University School of Medicine in New Orleans – and also includes six research partners: LSU Health Sciences Center in Shreveport, Louisiana State University in Baton Rouge, and in New Orleans, Xavier University of Louisiana, Children’s Hospital, Ochsner Health System, Southeast Louisiana Veterans Health Care System, and University Medical Center.  The LA CaTS Center’s vision for Louisiana encompasses the strengths and capacities unique to each member institution and represents a unified, comprehensive approach for targeting prevention, care and research of chronic diseases in the underserved population.  The scholar program is supported in part by U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health which funds the Louisiana Clinical and Translational Science Center.  For more information, please visit www.lacats.org.